Literature DB >> 16414338

Bilateral oophorectomy and premature menopause.

Susan L Hendrix1.   

Abstract

The ovary is a complex metabolic organ. The follicles produce both androgens and estrogens, whereas the stromal tissue synthesizes androgens only. When menopause occurs, both androgen and estrogen levels decrease. The postmenopausal ovary remains a source of endogenous androgens that are converted to estrogen. The consequences of premature removal of the ovaries are not well known. The risks and benefits of menopausal hormone therapy (HT) in women with premature menopause have not been studied. Women who have had surgical menopause experience more severe symptoms and will need to stop estrogen therapy at some point in their lives. Intense symptoms such as hot flashes, night sweats, and insomnia will redevelop, so women should be given informed consent about the need for long-term use of HT and the greater difficulty in discontinuing therapy.

Entities:  

Mesh:

Year:  2005        PMID: 16414338     DOI: 10.1016/j.amjmed.2005.09.056

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study.

Authors:  Elizabeth A Hibler; James Kauderer; Mark H Greene; Gustavo C Rodriguez; David S Alberts
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

2.  Women's Reproductive History and Pre-Clinical Peripheral Arterial Disease in Late Life: The San Diego Population Study.

Authors:  Yamnia I Cortés; Nisha Parikh; Matthew A Allison; Michael H Criqui; Natalie Suder; Emma Barinas-Mitchell; Christina L Wassel
Journal:  J Womens Health (Larchmt)       Date:  2018-12-01       Impact factor: 2.681

Review 3.  Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Authors:  Nancy E Avis; Sybil L Crawford; Robin Green
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

4.  Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation.

Authors:  Kim Sutton-Tyrrell; Xinhua Zhao; Nanette Santoro; Bill Lasley; MaryFran Sowers; Janet Johnston; Rachel Mackey; Karen Matthews
Journal:  Am J Epidemiol       Date:  2010-04-27       Impact factor: 4.897

5.  Postoophorectomy estrogen use and breast cancer risk.

Authors:  Hazel B Nichols; Amy Trentham-Dietz; Polly A Newcomb; Linda J Titus; Kathleen M Egan; John M Hampton; Kala Visvanathan
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

6.  Salivary sex hormone measurement in a national, population-based study of older adults.

Authors:  Natalia Gavrilova; Stacy Tessler Lindau
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-02-09       Impact factor: 4.077

7.  Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer.

Authors:  Hazel B Nichols; Amy Trentham-Dietz; Polly A Newcomb; Kathleen M Egan; Linda J Titus; John M Hampton; Kala Visvanathan
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

8.  Efficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma.

Authors:  Yong-Li Zhang; Jin-Hong Chen; Wen Lu; Bi-Lan Li; Qin-Yi Zhu; Xiao-Ping Wan
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

9.  Changing trends in Black-White racial differences in surgical menopause: a population-based study.

Authors:  Maya A Wright; Kemi M Doll; Evan Myers; William R Carpenter; Danielle R Gartner; Whitney R Robinson
Journal:  Am J Obstet Gynecol       Date:  2021-06-08       Impact factor: 10.693

10.  Short-Term Isoflavone Intervention in the Treatment of Severe Vasomotor Symptoms after Surgical Menopause: A Case Report and Literature Review.

Authors:  Supanimit Teekachunhatean; Natnita Mattawanon; Surapan Khunamornpong
Journal:  Case Rep Obstet Gynecol       Date:  2015-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.